Q32 Bio, Inc. (QTTB)
5.14
-0.23
(-4.28%)
USD |
NASDAQ |
May 11, 15:47
Q32 Bio Revenue (Quarterly) : 0.00 for March 31, 2026
Revenue (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Revenue (Quarterly) Benchmarks
| Agenus, Inc. | 34.20M |
| Inovio Pharmaceuticals, Inc. | 0.00 |
| Ironwood Pharmaceuticals, Inc. | 106.51M |
| AbbVie, Inc. | 15.00B |
| Armata Pharmaceuticals, Inc. | 1.085M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.609M |
| Total Expenses (Quarterly) | 7.609M |
| EPS Diluted (Quarterly) | -0.5398 |
| Enterprise Value | 53.95M |
| Earnings Yield | 51.81% |
| Operating Earnings Yield | 32.59% |
| Normalized Earnings Yield | 52.48 |